{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:46:09Z","timestamp":1792727169084,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204797\/Z\/16\/Z"],"award-info":[{"award-number":["204797\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194"],"award-info":[{"award-number":["206194"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206508\/Z\/17\/Z"],"award-info":[{"award-number":["206508\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.xcrm.2021.100487","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T10:31:57Z","timestamp":1640860317000},"page":"100487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV"],"prefix":"10.1016","volume":"3","author":[{"given":"Yegnasew","family":"Takele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadele","family":"Mulaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emebet","family":"Adem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-2976","authenticated-orcid":false,"given":"Caroline Jayne","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4725-1793","authenticated-orcid":false,"given":"Susanne Ursula","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Womersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrsini","family":"Kaforou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-2390","authenticated-orcid":false,"given":"Graham Philip","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Anthony","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Kropf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100487_bib1","first-page":"265","article-title":"Global leishmaniasis surveillance, 2017\u20132018, and first report on 5 additional indicators","volume":"25","author":"Ruiz-Postigo","year":"2020","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.xcrm.2021.100487_bib2","series-title":"Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010","year":"2010"},{"key":"10.1016\/j.xcrm.2021.100487_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13071-015-0987-y","article-title":"Eco-epidemiology of visceral leishmaniasis in Ethiopia","volume":"8","author":"Gadisa","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.xcrm.2021.100487_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0163-4453(99)90001-4","article-title":"Visceral leishmaniasis in clinical practice","volume":"39","author":"Davidson","year":"1999","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.xcrm.2021.100487_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.xcrm.2021.100487_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.xcrm.2021.100487_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","article-title":"The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms","volume":"97","author":"Olivier","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.xcrm.2021.100487_bib8","doi-asserted-by":"crossref","first-page":"e3131","DOI":"10.1371\/journal.pntd.0003131","article-title":"Visceral leishmaniasis in Ethiopia: an evolving disease","volume":"8","author":"Leta","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib9","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1371\/journal.pntd.0002875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"Diro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia","volume":"15","author":"Hurissa","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.xcrm.2021.100487_bib12","doi-asserted-by":"crossref","first-page":"e0007132","DOI":"10.1371\/journal.pntd.0007132","article-title":"Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia","volume":"13","author":"Diro","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib13","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib14","doi-asserted-by":"crossref","first-page":"e0006527","DOI":"10.1371\/journal.pntd.0006527","article-title":"The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: a retrospective cohort study","volume":"12","author":"Abongomera","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcimb.2018.00094","article-title":"Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis\/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia","volume":"8","author":"van Griensven","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100487_bib16","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"ter Horst","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2005.06.015","article-title":"T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani","volume":"117","author":"Hailu","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib18","doi-asserted-by":"crossref","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-\u03b3, but not IL-10 Production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0036-46652009000500002","article-title":"Immunoactivation and immunopathogeny during active visceral leishmaniasis","volume":"51","author":"Goto","year":"2009","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.xcrm.2021.100487_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib22","series-title":"Guideline for diagnosis, treatment & prevention of leishmaniasis in Ethiopia, 2nd edition","year":"2013"},{"issue":"3, e0097121","key":"10.1016\/j.xcrm.2021.100487_bib23","doi-asserted-by":"crossref","first-page":"e0097121","DOI":"10.1128\/mBio.00971-21","article-title":"Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia","volume":"12","author":"Franssen","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.xcrm.2021.100487_bib25","doi-asserted-by":"crossref","first-page":"e0005727","DOI":"10.1371\/journal.pntd.0005727","article-title":"Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites","volume":"11","author":"Tajebe","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib72","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.celrep.2020.01.099","article-title":"Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis","volume":"30","author":"Kumar","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.xcrm.2021.100487_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T\u00a0cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib27","doi-asserted-by":"crossref","first-page":"100583","DOI":"10.1016\/j.curtheres.2020.100583","article-title":"Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia","volume":"92","author":"Mohammed","year":"2020","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.xcrm.2021.100487_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/cid\/ciab124","article-title":"Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa","volume":"73","author":"Verrest","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib29","series-title":"National guidelines for comprehensive HIV prevention, care, and treatment.","year":"2017"},{"key":"10.1016\/j.xcrm.2021.100487_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2334-10-358","article-title":"High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load","volume":"10","author":"Santos-Oliveira","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib31","first-page":"152","article-title":"Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy","volume":"13","author":"Jim\u00e9nez-Exp\u00f3sito","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2021.100487_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s100960100457","article-title":"Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy","volume":"20","author":"Casado","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib33","doi-asserted-by":"crossref","first-page":"e1977","DOI":"10.1371\/journal.pntd.0001977","article-title":"Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection","volume":"7","author":"Takele","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib34","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pmed.0040115","article-title":"Malnutrition and infection: complex mechanisms and global impacts","volume":"4","author":"Schaible","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2021.100487_bib35","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1753-4887.1998.tb01649.x","article-title":"Protein, calories, and immune defenses","volume":"56","author":"Woodward","year":"1998","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.xcrm.2021.100487_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fphar.2020.00481","article-title":"Impact of TNF-\u03b1 Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis","volume":"11","author":"Patsalos","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100487_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V3.3.249.249","article-title":"Studies on the pancytopenia of kala-azar","volume":"3","author":"Cartwright","year":"1948","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100487_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fimmu.2016.00153","article-title":"The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis","volume":"7","author":"de Freitas","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12288-010-0027-1","article-title":"Hematologic changes in visceral leishmaniasis\/kala azar","volume":"26","author":"Varma","year":"2010","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.xcrm.2021.100487_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fcimb.2020.00060","article-title":"Hematopoietic Stem\/Progenitor Cells and the Pathogenesis of HIV\/AIDS","volume":"10","author":"Tsukamoto","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100487_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fimmu.2016.00364","article-title":"Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output","volume":"7","author":"Pascutti","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri3062","article-title":"Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response","volume":"11","author":"King","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib43","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","article-title":"Leishmania specific CD4 T\u00a0cells release IFN\u03b3 that limits parasite replication in patients with visceral leishmaniasis","volume":"8","author":"Kumar","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T\u00a0cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-6-59","article-title":"CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa","volume":"6","author":"Lawn","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib46","doi-asserted-by":"crossref","first-page":"e0240880","DOI":"10.1371\/journal.pone.0240880","article-title":"Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia","volume":"15","author":"Wolday","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100487_bib47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100487_bib48","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/QAD.0000000000001801","article-title":"Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa","volume":"32","author":"Kroeze","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2021.100487_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAD.0000000000002458","article-title":"Associations between recent thymic emigrants and CD4+ T-cell recovery after short-term antiretroviral therapy initiation","volume":"34","author":"Brice\u00f1o","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2021.100487_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3389\/fimmu.2020.00953","article-title":"Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV\/AIDS Patients","volume":"11","author":"Silva-Freitas","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib51","doi-asserted-by":"crossref","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","article-title":"HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T\u00a0cell subsets, heightened CD8+ T\u00a0cell activation, and increased risk of non-AIDS morbidity and mortality","volume":"10","author":"Serrano-Villar","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100487_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.03.002","article-title":"Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort","volume":"117","author":"Pacheco","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.xcrm.2021.100487_bib53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu038","article-title":"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery","volume":"58","author":"Engsig","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib54","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2352-3018(20)30231-9","article-title":"End resistance to dolutegravir roll-out","volume":"7","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2021.100487_bib55","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1371\/journal.pntd.0002134","article-title":"Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia","volume":"7","author":"Abebe","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib56","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.celrep.2018.06.107","article-title":"IRF-5 Promotes Cell Death in CD4\u00a0T Cells during Chronic Infection","volume":"24","author":"Fabi\u00e9","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2021.100487_bib57","first-page":"605","article-title":"Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis","volume":"33","author":"Veress","year":"1977","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2021.100487_bib58","doi-asserted-by":"crossref","first-page":"ofx262","DOI":"10.1093\/ofid\/ofx262","article-title":"Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial","volume":"4","author":"Baker","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","article-title":"Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection","volume":"64","author":"Sereti","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/v11030200","article-title":"Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART","volume":"11","author":"Zicari","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2021.100487_bib61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion.\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The Role of PD-1 in Acute and Chronic Infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100487_bib64","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.xcrm.2021.100487_bib65","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/167.Supplement_1.S13","article-title":"The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis","volume":"167","author":"Badaro","year":"1993","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100487_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1983.32.475","article-title":"Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis","volume":"32","author":"Chulay","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.xcrm.2021.100487_bib69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121003591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121003591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:49:14Z","timestamp":1762987754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121003591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2666379121003591"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100487","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.30.437646","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100487"}}